These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7679923)

  • 1. Design and synthesis of RNA miniduplexes via a synthetic linker approach.
    Ma MY; Reid LS; Climie SC; Lin WC; Kuperman R; Sumner-Smith M; Barnett RW
    Biochemistry; 1993 Feb; 32(7):1751-8. PubMed ID: 7679923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of RNA miniduplexes via a synthetic linker approach. 2. Generation of covalently closed, double-stranded cyclic HIV-1 TAR RNA analogs with high Tat-binding affinity.
    X Ma MY; McCallum K; Climie SC; Kuperman R; Lin WC; Sumner-Smith M; Barnett RW
    Nucleic Acids Res; 1993 Jun; 21(11):2585-9. PubMed ID: 8332456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of human immunodeficiency virus type 1 Tat-derived peptides with TAR RNA.
    Long KS; Crothers DM
    Biochemistry; 1995 Jul; 34(27):8885-95. PubMed ID: 7612630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligonucleotide inhibition of the interaction of HIV-1 Tat protein with the trans-activation responsive region (TAR) of HIV RNA.
    Mestre B; Arzumanov A; Singh M; Boulmé F; Litvak S; Gait MJ
    Biochim Biophys Acta; 1999 Apr; 1445(1):86-98. PubMed ID: 10209261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel HIV-1 TAR RNA bulge binding protein.
    Baker B; Muckenthaler M; Vives E; Blanchard A; Braddock M; Nacken W; Kingsman AJ; Kingsman SM
    Nucleic Acids Res; 1994 Aug; 22(16):3365-72. PubMed ID: 8078772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing Tat peptide-TAR RNA interactions by psoralen photo-cross-linking.
    Wang Z; Shah K; Rana TM
    Biochemistry; 2001 May; 40(21):6458-64. PubMed ID: 11371209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein.
    Aboul-ela F; Karn J; Varani G
    J Mol Biol; 1995 Oct; 253(2):313-32. PubMed ID: 7563092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a polyethylene glycol-peptide conjugate in a competition gel shift assay for screening potential antagonists of HIV-1 Tat protein binding to TAR RNA.
    Wang J; Huang SY; Choudhury I; Leibowitz MJ; Stein S
    Anal Biochem; 1995 Dec; 232(2):238-42. PubMed ID: 8747481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical cross-linking of the human immunodeficiency virus type 1 Tat protein to synthetic models of the RNA recognition sequence TAR containing site-specific trisubstituted pyrophosphate analogues.
    Naryshkin NA; Farrow MA; Ivanovskaya MG; Oretskaya TS; Shabarova ZA; Gait MJ
    Biochemistry; 1997 Mar; 36(12):3496-505. PubMed ID: 9131999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrogen-bonding contacts in the major groove are required for human immunodeficiency virus type-1 tat protein recognition of TAR RNA.
    Hamy F; Asseline U; Grasby J; Iwai S; Pritchard C; Slim G; Butler PJ; Karn J; Gait MJ
    J Mol Biol; 1993 Mar; 230(1):111-23. PubMed ID: 8450529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flexible non-nucleotide linkers as loop replacements in short double helical RNAs.
    Pils W; Micura R
    Nucleic Acids Res; 2000 May; 28(9):1859-63. PubMed ID: 10756183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185.
    Wu F; Garcia J; Sigman D; Gaynor R
    Genes Dev; 1991 Nov; 5(11):2128-40. PubMed ID: 1936997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation.
    Roy S; Delling U; Chen CH; Rosen CA; Sonenberg N
    Genes Dev; 1990 Aug; 4(8):1365-73. PubMed ID: 2227414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the solution conformations of unbound and Tat peptide-bound forms of HIV-1 TAR RNA.
    Long KS; Crothers DM
    Biochemistry; 1999 Aug; 38(31):10059-69. PubMed ID: 10433713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proximity of a Tat peptide to the HIV-1 TAR RNA loop region determined by site-specific photo-cross-linking.
    Wang Z; Huq I; Rana TM
    Bioconjug Chem; 1999; 10(3):512-9. PubMed ID: 10346885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides.
    Arzumanov A; Walsh AP; Rajwanshi VK; Kumar R; Wengel J; Gait MJ
    Biochemistry; 2001 Dec; 40(48):14645-54. PubMed ID: 11724578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV gene regulatory proteins tat and rev and their interactions with synthetic RNA.
    Asseline U; Grasby J; Hamy F; Iwai S; Mann DA; Pritchard C; Karn J; Gait MJ
    Nucleic Acids Symp Ser; 1993; (29):113-4. PubMed ID: 7504239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-specific cross-linking of amino acids in the basic region of human immunodeficiency virus type 1 Tat peptide to chemically modified TAR RNA duplexes.
    Farrow MA; Aboul-ela F; Owen D; Karpeisky A; Beigelman L; Gait MJ
    Biochemistry; 1998 Mar; 37(9):3096-108. PubMed ID: 9485463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refolded HIV-1 tat protein protects both bulge and loop nucleotides in TAR RNA from ribonucleolytic cleavage.
    Harper JW; Logsdon NJ
    Biochemistry; 1991 Aug; 30(32):8060-6. PubMed ID: 1868081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition.
    Calnan BJ; Biancalana S; Hudson D; Frankel AD
    Genes Dev; 1991 Feb; 5(2):201-10. PubMed ID: 1899841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.